Trial intelligence / Profile preview

Dexmedetomidine vs Chloral Hydrate for EEG Sedation

NCT01083797Phase 3Completed

Sponsor
Universidade Federal de Minas Gerais
Start
Dec 2009
Primary completion
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of dexmedetomidine in neurological disorder, sponsored by Universidade Federal de Minas Gerais. Started Dec 2009; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

neurological disorder

Beyond the preview

Go deeper on NCT01083797.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01083797.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call